Heterogeneity of lung disease associated with NK2 homeobox 1 mutations.

[1]  A. Clément,et al.  Respiratory Distress, Congenital Hypothyroidism and Hypotonia in a Newborn , 2016, Respiration.

[2]  R. Ficarella,et al.  14q13 distal microdeletion encompassing NKX2‐1 and PAX9: Patient report and refinement of the associated phenotype , 2016, American journal of medical genetics. Part A.

[3]  A. Nicholson,et al.  European protocols for the diagnosis and initial treatment of interstitial lung disease in children , 2015, Thorax.

[4]  J. Whitsett,et al.  Diseases of pulmonary surfactant homeostasis. , 2015, Annual review of pathology.

[5]  H. Morris,et al.  Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum , 2014, Developmental medicine and child neurology.

[6]  H. Collard,et al.  Staging of idiopathic pulmonary fibrosis: past, present and future , 2014, European Respiratory Review.

[7]  H. Ropers,et al.  Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum , 2014, Journal of Medical Genetics.

[8]  P. Cogo,et al.  Respiratory insufficiency in a newborn with congenital hypothyroidism due to a new mutation of TTF‐1/NKX2.1 gene , 2014, Pediatric pulmonology.

[9]  C. Wallis,et al.  Ten‐year follow up of hydroxychloroquine treatment for ABCA3 deficiency , 2014, Pediatric pulmonology.

[10]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[11]  J. Rosenfeld,et al.  Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. , 2013, Chest.

[12]  G. Redding,et al.  American Thoracic Society Documents an Official American Thoracic Society Clinical Practice Guideline: Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy Contents Executive Summary Diagnosis Special Considerations Management Research Priorities Introduction , 2022 .

[13]  R. Epaud,et al.  Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin , 2013, BMJ Case Reports.

[14]  A. Bush,et al.  ABCA3 transporter deficiency. , 2012, American journal of respiratory and critical care medicine.

[15]  M. Vidailhet,et al.  Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  C. Delacourt,et al.  A national internet-linked based database for pediatric interstitial lung diseases: the French network , 2012, Orphanet Journal of Rare Diseases.

[17]  G. Schmitz,et al.  The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation , 2012, BMC Pulmonary Medicine.

[18]  P. Reix,et al.  Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation , 2011, Thorax.

[19]  R. Deterding.  Infants and Young Children with Children's Interstitial Lung Disease. , 2010, Pediatric allergy, immunology, and pulmonology.

[20]  F. Brunelle,et al.  Surfactant protein C gene (SFTPC) mutation‐associated lung disease: High‐resolution computed tomography (HRCT) findings and its relation to histological analysis , 2010, Pediatric pulmonology.

[21]  R. Epaud,et al.  Interstitial lung diseases in children , 2010, Orphanet journal of rare diseases.

[22]  H. Krude,et al.  Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[23]  P. Reix,et al.  Characteristics of disorders associated with genetic mutations of surfactant protein C , 2010, Archives of Disease in Childhood.

[24]  M. Polak,et al.  NKX2‐1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain‐Lung‐Thyroid Syndrome” , 2010, Human mutation.

[25]  M. Polak,et al.  Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. , 2009, Human molecular genetics.

[26]  J. Whitsett,et al.  Genetic Disorders of Surfactant Dysfunction , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[27]  J. Parma,et al.  Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  D. Devos,et al.  Psychosis, short stature in benign hereditary chorea: A novel thyroid transcription factor‐1 mutation , 2008, Movement disorders : official journal of the Movement Disorder Society.

[29]  P. Macchia,et al.  A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. , 2008, Thyroid : official journal of the American Thyroid Association.

[30]  R. Corkey,et al.  Beneficial response to macrolide antibiotic in a patient with desquamative interstitial pneumonia refractory to corticosteroid therapy. , 2008, Chest.

[31]  J. Pérez-Gil,et al.  Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. , 2008, Biochimica et biophysica acta.

[32]  L. Defebvre,et al.  New syndromic form of benign hereditary chorea is associated with a deletion of TITF‐1 and PAX‐9 contiguous genes , 2006, Movement disorders : official journal of the Movement Disorder Society.

[33]  F. Asmus,et al.  A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa , 2005, Neurology.

[34]  J. L. Yntema,et al.  Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene , 2005, European Journal of Pediatrics.

[35]  M. Polak,et al.  PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. , 2005, The Journal of clinical endocrinology and metabolism.

[36]  A. Clément,et al.  Task force on chronic interstitial lung disease in immunocompetent children , 2004, European Respiratory Journal.

[37]  R. Weiss,et al.  Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. , 2002, The Journal of clinical investigation.

[38]  A. von Deimling,et al.  Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. , 2002, The Journal of clinical investigation.

[39]  H. Delemarre-van de Waal,et al.  Glucocorticoids and lung development in the fetus and preterm infant , 2001, Pediatric pulmonology.

[40]  T. Weaver,et al.  Function of surfactant proteins B and C. , 2001, Annual review of physiology.

[41]  K. Devriendt,et al.  Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. , 2000, The Journal of pediatrics.

[42]  K. Devriendt,et al.  Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. , 1998, The New England journal of medicine.

[43]  C. Jones,et al.  Structure of the human Nkx2.1 gene. , 1998, Biochimica et biophysica acta.

[44]  C H Fox,et al.  The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.

[45]  M. Mattéi,et al.  Thyroid nuclear factor 1 (TTF‐1) contains a homeodomain and displays a novel DNA binding specificity. , 1990, The EMBO journal.